Tumor amplified protein expression therapy: Salmonella as a tumor-selective protein delivery vector

Oncology Research

Volumn 12, Issue 3, 2000, Pages 127-135

  Zheng, Li Mou ^a   Luo, Xiang ^a   Feng, Ming ^a   Li, Zujin ^a   Le, Trung ^a   Ittensohn, Martina ^a   Trailsmith, Mark ^a   Bermudes, David ^a   Lin, Stanley L ^a   King, Ivan C ^a  

^a Vion Pharmaceuticals Incorporated   (United States)

Author keywords

Cancer; Delivery; Prodrug converting enzyme; Salmonella; Targeting; Vector

Indexed keywords

CYTOSINE DEAMINASE; DEAMINASE; GREEN FLUORESCENT PROTEIN; PHOTOPROTEIN;

ANIMAL; ARTICLE; C57BL MOUSE; CELL CULTURE; EXPERIMENTAL NEOPLASM; GENE VECTOR; GENETICS; HUMAN; MOUSE; SALMONELLA;

ANIMALS; CYTOSINE DEAMINASE; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; LUMINESCENT PROTEINS; MICE; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; NUCLEOSIDE DEAMINASES; SALMONELLA; TUMOR CELLS, CULTURED;

EID: 0034572185     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504001108747602     Document Type: Article

References (24)

1. Gill, G. V.; Holden, A. A malignant pleural effusion infected with Salmonella enteritidis. Thorax 51:104-105; 1996.
2. Giel, C. P. Abscess formation in a pheochromocytoma. N. Engl. J. Med. 251:980-982; 1954.
3. Graham, F. O.; Coleman, P. N. Infection of a secondary carcinoma by Salmonella montevideo. Br. Med. J. 1:1116; 1952.
4. Pawelek, J.; Low, K. B.; Bermudes, D. Tumor-targeted Salmonella as a novel anti-cancer vector. Cancer Res. 57:4537-4544; 1997.
5. Chen, J. J.; Sun, Y.; Nabel, G. J. Regulation of the proinflammatory effects of Fas ligand (CD95L). Science 282:1714-1717; 1998.
6. Jain, R. K. Haemodynamic and transport barriers to the treatment of solid tumours. Int. J. Radiat. Biol. 60:85-100; 1991.
7. Hoiseth, S. K.; Stocker, B. A. D. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291:238-239; 1981.
8. Strugnell, R. A.; Maskell, D.; Fairweather, N.; Pickard, D.; Cockayne, A.; Penn, C.; Dougan, G. Stable expression of foreign antigens from the chromosome of Salmonella typhimurium vaccine strains. Gene 88:57-63; 1990.
9. Sizemore, D. R.; Branstorm, A. A.; Sadoff, J. C. Atteunuated Shigella as a DNA delivery vehicle for DNA-mediated immunization. Science 270:299-302; 1995.
10. Saltzman, D. A.; Heise, C. P.; Hasz, D. E.; Zebede, M.; Kelly, S. M.; Curtiss, R.; Leonard, A. S.; Anderson P. M. Attenuated Salmonella typhimurium containing interleukin-2 decreases MC-38 hepatic metastases: A novel anti-tumor agent. Cancer Biother. Radiopharm. 11:145-153; 1996.
11. Fox, M. E.; Lemmon, M. J.; Mauchline, M. L.; Davis, T. O.; Giaccia, A. J.; Minton, N. P.; Brown, J. M. Anaerobic bacteria as a delivery system for cancer gene therapy: In vitro activation of 5-fluorocytosine by genetically engineered Clostridia. Gene Ther. 3: 173-178; 1996.
12. Chatfield, S. N.; Charles, I. G.; Makoff, A. J.; Oxer, M. D.; Dougan, G.; Pickard, D.; Slater, D.; Fairweather, N. F. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: Development of a single-dose oral tetanus vaccine. Biotechnology 10:888-892; 1992.
13. Levin, M. M.; Herrington, D.; Murphy, J. R.; Morris, J. G.; Losonsky, G.; Tall, B.; Lindberg, A. A.; Svenson, S.; Baqar, S.; Edwards, M. F.; Stocker, B. Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi. J. Clin. Invest. 79:888-902; 1987.
14. Low, K. B.; Ittensohn, M.; Le, T.; Platt, J.; Sodi, S.; Amoss, M.; Ash, O.; Carmichael, E.; Chakraborty, A.; Fischer, J.; Lin, S. L.; Luo, X.; Miller, S. I.; Zheng, L.-M.; King, I.; Pawalek, J. M.; Bermudes, D. Lipid A mutant Salmonella with suppressed virulence and TNF-α induction retain tumor-targeting in vivo. Nat. Biotech. 17:37-41; 1999.
15. Laliberte, J.; Momparler, R. L. Human cytidine deaminease: Purification of enzyme, cloning, and expression of its complementary DNA. Cancer Res. 54:5401-5407; 1994.
16. [Q1] E. A.; Ohwada, A.; Pascal, W. R.; Russi, T. L.; Crystal, R. G. In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine. Hum. Gene Ther. 6:1055-1063; 1995.
17. Muller, W. J.; Sinn, E.; Pattengale, P. K.; Wallace, R.; Leder, P. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54:105-115; 1988.
18. Page-Clisson, M.-E.; Pinto-Alphandary, H.; Chachaty, E.; Couvreur, P.; Andremont, A. Drug targeting by polyalkylcyanoacrylate nanoparticles is not efficient against persistent Salmonella. Pharmaceut. Res. 15:544-549; 1998.
19. Lambin, P.; Theys, J.; Landuyt, W.; Rijken, P.; van der Kogel, A.; van der Schueren, E.; Hodgkiss, R.; Fowler, J.; Nuyts, S.; de Bruijn, E.; Van Mellaert, L.; Anne, J. Colonisation of Clostridium in the body is restricted to hypoxic and necrotic areas of tumours. Anaerobe 4:183-188; 1998.
20. Carey, R. W.; Holland, J. F.; Whang, H. Y.; Neter, E.; Bryant, B. Clostridial oncolysis in man. Eur. J. Cancer 3:37-46; 1967.
21. Connors, T. A. The choice of prodrugs for gene directed enzyme prodrug therapy of cancer. Gene Ther. 2:702-709; 1995.
22. Low, K. B.; Ittensohn, M.; Lin, S.; Clairmont, C.; Luo, X.; Zheng, L-M.; King, I.; Pawelek, J. M.; Bermudes, D. VNP20009, a genetically modified Salmonella typhimurium for treatment of solid tumors. Proc. Am. Assoc. Can. Res. 40:87; 1999.
23. Lee, K.; Zheng, L-M.; Luo, X.; Clairmont, C.; Fischer, J.; Margitich, D.; Turnier, J.; Almassian, B.; King, I. Comparative toxicological evaluation in monkeys, pigs, and mice, of a genetically-engineered Salmonella (VNP20009) being developed as an anti-tumor agent. Int. J. Toxicol. 19:19-25, 2000.
24. Clairmont, C.; Lee, K. C.; Pike, J.; Ittensohn, M.; Low, K. B.; Pawelek, J.; Bermudes, D.; Brecher, S. M.; Margitich, D.; Turnier, J.; Li, Z.; Luo, X.; King, I.; Zheng, L. M. Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium. J. Infect. Dis. 181:1996-2002; 2000.